In tumor cells from a SCLC patient who received methotrexate (MTX), a large quantity of DMs was discovered, and the gene coding for dihydrofolate reductase (DHFR) was amplified and overexpressed 106. This evidence concerns the gene DHFR and small cell lung carcinoma.